Stock Events

Stock Events

UroGen Pharma (URGN) Q2 2023 Earnings

10AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-1.33

-1.23

-1.13

-1.03

Details

Expected EPS

-1.14

Actual EPS

-1.03

Surprise EPS

0.11

Surprise Percent

+9.65%

Description

UroGen Pharma (URGN) has reported earnings of -1.03 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.